Bill 21 amended the Drug and Pharmacies Regulation Act
("DPRA") to extend oversight and investigative authority
of the Ontario College of Pharmacists ("OCP") to hospital
pharmacies, which include those locations where drugs are
compounded, dispensed or supplied for hospital patients. These
amendments will only come into force after DPRA regulations (which
currently only apply to community pharmacies) are amended to
address these pharmacy locations.
OCP Public Consultation – Written Feedback Requested
The OCP has released proposed revisions to Ontario Regulation
58/11 under the DPRA and is seeking feedback on the changes.
The deadline to provide feedback is May 10,
Proposed revisions include establishing two classes of pharmacy
accreditation; one for community pharmacies and one for hospital
pharmacies. Institutional pharmacy locations are not currently
addressed in the proposed regulations. Performance-based
expectations applicable to pharmacies of all classes of
certificates of accreditation are also outlined in the
The OCP's revisions are intended to be high-level in order
to support future changes in scope of practice for health
professionals and evolution in related technology. Standards,
policies and guidelines will be developed to support the regulation
by referencing national standards, addressing specific issues and
ensuring clarity of policy expectations.
The proposed revisions, information on how to provide feedback
and OCP considerations when making the proposed revisions can be
found on the OCP website. You may also inquire with us
directly if you have any questions.
Miller Thomson will continue to monitor the progress of
revisions to the DPRA regulation and keep you apprised of any
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
Effective September 1, 2016, the Disposition of Surplus Real Property Regulation to the Ontario Education Act was amended with the intention to reduce barriers to the formation of health and community hubs in Ontario.
This appeal relates to two generic drug submissions for two different products: exemestane and infliximab. Both submissions cross-referenced the submission of another generic company that had received a Notice of Compliance.
Two recent decisions from the Supreme Court of Canada directly affect Quebec's farm businesses by confirming La Financière Agricole du Québec's discretion in the administration of the farm income stabilization program...
On October 6, 2016, the Ontario Legislature reintroduced the Patients First Act, 2016 as Bill 41. Bill 41 is very similar to its predecessor, Bill 210, which was introduced in June 2016, but makes some important changes to the previous bill.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).